Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00044967 · ClinicalTrials.gov registry record
Genetic Study of Young Patients With Colorectal Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 651
- Enrollment target
NCT00044967: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00044967 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 651 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00044967 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 651 participants
- Enrollment target
Study Summary
RATIONALE: Identifying gene mutations (microsatellite instability) may allow doctors to plan effective treatment for patients who develop colorectal cancer at an early age. PURPOSE: Genetic trial to determine the significance of gene mutations in helping predict the outcome of treatment in patients who develop stage I, stage II, or stage III colorectal cancer at an early age.
Interventions
- GENETIC microsatellite instability analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 651 participants |
| Start Date | 2002-05 |
| Est. Completion | 2004-12 |
What the finished NCT00044967 record still lists
NCT00044967 is an observational study that tracks outcomes without assigning an intervention. The registered 651 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which microsatellite instability analysis is the first listed.
NCT00044967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00044967 about?
NCT00044967 is a clinical study titled "Genetic Study of Young Patients With Colorectal Cancer". RATIONALE: Identifying gene mutations (microsatellite instability) may allow doctors to plan effective treatment for patients who develop colorectal cancer at an early age. PURPOSE: Genetic trial to determine the significance of gene mutations in helping predict the outcome of treatment in patients...
What is the current status of trial NCT00044967?
This trial is currently completed. The enrollment target is 651 participants. The study started on 2002-05. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00044967?
The interventions under investigation include: microsatellite instability analysis (GENETIC).
Who is sponsoring clinical trial NCT00044967?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06287346 · 652 participants
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia